Health
Drug Trials Snapshots: QFITLIA
QFITLIA is an antithrombin-directed small interfering ribonucleic acid indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without fac…
FDA.gov · 5 days ago